Creating the Access Backbone for a Leading Rare Disease Portfolio

This customer had three in-line therapies across Immunology, Hematology, and Infectious Disease with another five therapies in phase III clinical trials. As is the case with many specialty therapies, the level of competition was increasing, driving the need for more aggressive commercial contracting and rebating. Having worked as their data aggregator and supported their current, third-party BPO platform, IntegriChain understood how difficult it was going to be for their commercial team to create and adjudicate these new commercial contracts and rebates using their legacy revenue management system and manual, error-prone processes. Download below!